Neurobell
- Business Model
- B2B
- Website
- neurobell.com
- Total Funding
- $5.5M
- Last Round
- $5.5M SeedJun 2026
- Rounds
- 3
About
NeuroBell develops artificial-intelligence-powered neonatal brain-monitoring technology for clinicians and vulnerable newborn patients. The company combines patent-pending medical technology, deep-learning models, and clinically annotated EEG datasets to expand access to advanced monitoring. Its first product, NeuroBell Luna, is being clinically validated ahead of regulatory submission, following research originating at University College Cork and the INFANT Research Centre.
Summary
Neurobell is a Healthcare company. It has raised $5.5M in total across 3 rounds, most recently a $5.5M Seed round in Jun 2026. Investors include Elkstone Partners, Furthr VC and Atlantic Bridge.
Funding History
Jun 2026
Sign up to see all 3 rounds
Seed through Series A — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
S4 Medical develops FDA-cleared devices that help physicians protect the esophagus during cathete...
Neko Health delivers preventive health scans that combine skin, heart, blood, and body measuremen...
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/neurobell"><img src="https://indexed.vc/api/badge/company/neurobell" alt="Neurobell on Indexed.vc" width="260" height="76" /></a>